Status:
COMPLETED
Monitoring of Postprandial Glycemic Variability in Healthy Young Infants
Lead Sponsor:
University of Lausanne Hospitals
Collaborating Sponsors:
Société des Produits Nestlé (SPN)
Conditions:
Infant Conditions
Glucose Intolerance
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
To measure and quantify the postprandial glucose variations in response to a meal in the healthy 6-12 months old child and correlate this response with the composition of this meal.
Detailed Description
14 full-term infants (boys and girls) aged six to twelve months and fed a diversified diet including infant formula, solid foods such as mixed meat and vegetable preparation or marketed preparations w...
Eligibility Criteria
Inclusion
- Term infants (boys and girls)
- 6 to 12 months old
- In good general health
- Nourished with diverse nutrition including infant formula, solid foods such as mixed meat and vegetable preparation or marketed preparations
- Infant child: if the child is breastfed partially, it can be included in the study. In this case, only samples of a food supplement will be collected for evaluation of the composition.
- Hospitalized at the Lausanne Children's Hospital for non-severe reasons that do not affect or suspect to affect glucose metabolism
- Measures of feeding (time and compositions with samples) feasible for 3 consecutive days by the parents at home
Exclusion
- Child born premature
- One or both parents with type 2 diabetes or gestational diabetes
- Child totally breastfed
- Chronic skin condition such as eczema, excessive dryness.
- Allergy known to adhesive plaster
- Infectious diseases affecting the skin (eg chickenpox, scarlet fever,)
- disorders of cutaneous microcirculation
- Infants suffering from diseases affecting nutrition or digestion (diarrheal gastroenteritis) and children undergoing antibiotic treatment that may affect gastrointestinal absorption
- Magnetic Resonance Imaging (MRI), Computed Tomography (CT), or Diathermy Therapy
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03819725
Start Date
January 14 2019
End Date
April 30 2021
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Endocrinology, Diabetology and Obesity Unit, Service of Pediatrics, Lausanne University Hospital
Lausanne, Canton of Vaud, Switzerland, 1011